beta
PRAN
Prana Biotechnology Ltd
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Prana Biotechnology Ltd is engaged in the development of therapeutic drugs designed to treat the causes of degeneration of the brain as the aging process progresses including Alzheimer's disease, Huntington's disease and Parkinson's disease.
Market Cap: 25.4 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.pranabio.com
Shares Outstanding: 8.9 Million
Float: 8.9 Million
Dividend: 0.0 (0.0%)
Beta: -0.194976
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 2177 trading days
From: 2014-01-30 To: 2019-04-08
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-03-24 | 6.0 | 1.0 | 6.0 |